Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00001656Phase 4Completed
Phase 4, randomised, double-blind trial in schizophrenia, psychotic disorder and schizoaffective disorder comparing Olanzapine with Clozapine (2 arms). Primary endpoints: Scale for the Assessment of Negative Symptoms at 8 weeks, Clinical Global Impression Severity of Symptoms Scale at 8 weeks and 6 more. Started Jun 1997; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00001656.